Bharat Book Bureau

Archives for medicines

Any assessment of China must consider the huge variations to be found in such a populous and geographically diverse country. * How is the population distributed? How is healthcare delivered? * Health funding: Who pays, who gets? * What are the real effects of the urban/rural divide on health provision? * Which regions are better… » read more

Posted by bharatbook

Features and benefits of this thoroughly-researched and highly-regarded management report: High quality: Original research, novel 5-year market forecasts and informed commentary from our experienced editors are allied with unrivalled primary source data Global coverage: Covers leading economies as well as key emerging markets such as Russia and Brazil Issue driven: Understand the latest company, product,… » read more

Posted by bharatbook

The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global biologics market expected to lose some degree of protection by 2019. All major countries now make provision for an abbreviated… » read more

Posted by bharatbook

Public healthcare costs are rising. Governments need to get them under control. In Europe, that means the systematic use of health technology assessments (HTA) and reference pricing. The US, on the other hand, focuses on comparative effectiveness research (CER) to identify drugs that maximise clinical efficacy, minimise clinical harm and are more in tune with… » read more

Posted by bharatbook

For years, their voices went unheard. And their opinions were ignored. But not anymore. Thanks to the internet and social media, there is a growing and vocal group of Key Opinion Leaders (KOLs) who are not necessarily academics or people who talk at conferences. Rather, they are bloggers, pundits and healthcare professionals whose voices and… » read more

Posted by bharatbook

What does the future hold for drug delivery technologies? Visiongain’s report shows you potential revenues and other trends, with data, forecasts and discussions. This decade, many commercial opportunities for improved drug delivery exist. You discover sales predictions to 2022 at world market, submarket, application and national level. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/drug-delivery-technologies-commercial-prospects-2012-2022.html In particular, our report forecasts six submarkets… » read more

Posted by bharatbook

Where are antithrombotic and anticoagulant treatments heading? Visiongain’s report shows you potential revenues to 2022, with data, forecasts and discussions. This study assesses drugs to treat abnormal blood clotting in human beings. Discover sales predictions at world market, therapeutic class, product and national levels to 2022. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/antithrombotic-anticoagulant-drugs-world-market-2012-2022.html How will products – Plavix, Lovenox, Pletal, Fragmin,… » read more

Posted by bharatbook

Bharatbook added a new report on “Pharmaceutical Pricing & Distribution in Japan, 2010 Update” into its market report catalogue for reselling. Pharmaceutical Pricing & Distribution in Japan, 2010 Update The author’s 2008 major title ‘Pharmaceutical Pricing & Distribution in Japan’ was described by PhRMA Japan as ‘a superb report…to understand Japan there is nothing better’.… » read more

Posted by bharatbook